Nadolol binding to human serum proteins.
Article Details
- CitationCopy to clipboard
Patel L, Johnson A, Turner P
Nadolol binding to human serum proteins.
J Pharm Pharmacol. 1984 Jun;36(6):414-5. doi: 10.1111/j.2042-7158.1984.tb04413.x.
- PubMed ID
- 6146679 [ View in PubMed]
- Abstract
Nadolol protein binding was measured in serum from 95 healthy subjects. Binding was found to range between 4 and 27%, with a mean of 14 +/- 4% (s.d.). There was a small but significant correlation found between the degree of nadolol binding and the serum alpha-1-acid glycoprotein concentration. However it was concluded that changes in the serum protein binding of nadolol were unlikely to give rise to any untoward clinical effects.
DrugBank Data that Cites this Article
- Drugs
- Drug Carriers
Drug Carrier Kind Organism Pharmacological Action Actions Nadolol alpha1-acid glycoprotein (Protein Group) Protein group Humans UnknownBinderDetails